col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Cell Reports
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―28 No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing Nathan Smits, Jay Rasmussen, Gabriela O. Bodea, Alberto A. Amarilla, Patricia Gerdes, Francisco J. Sanchez-Luque, et al. (+9)
2 [GO] 2021―Jul―23 Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated with Effective Immune Response to SARS-CoV-2 in BNT162b2 mRNA Vaccine Recipients Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, Matthew Angel, Jenifer Bear, Dimitris Stellas, et al. (+9)
3 [GO] 2021―Jul―20 Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication Caroline G. Williams, Alexander S. Jureka, Jesus A. Silvas, Anthony M. Nicolini, Stacie A. Chvatal, Jared Carlson-Stevermer, et al. (+3)
4 [GO] 2021―Jul―20 Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding Jakob Trimpert, Kristina Dietert, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, et al. (+12)
5 [GO] 2021―Jul―17 Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li
6 [GO] 2021―Jul―10 Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice David R. Martinez, Alexandra Scha¨fer, Sarah R. Leist, Dapeng Li, Kendra Gully, Boyd Yount, et al. (+9)
7 [GO] 2021―Jul―10 An intranasal vaccine durably protects against SARS-CoV-2 variants in mice Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, Baoling Ying, Dansu Yaun, Saravanan Raju, et al. (+13)
8 [GO] 2021―Jul―07 A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Leila Abassi, Thomas Klünemann, et al. (+35)
9 [GO] 2021―Jul―07 Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Fernando Martinez, et al. (+28)
10 [GO] 2021―Jun―29 Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 Jason Neidleman, Xiaoyu Luo, Ashley F. George, Matthew McGregor, Junkai Yang, Cassandra Yun, et al. (+8)
11 [GO] 2021―Jun―29 A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Houda H. Harastani, Allison Soung, Xiaoping Jiang, et al. (+10)
12 [GO] 2021―Jun―29 SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, et al. (+9)
13 [GO] 2021―Jun―26 Antibody landscape against SARS-CoV-2 proteome reveals significant differences between non-structural/ accessory proteins and structural proteins Yang Li, Zhaowei Xu, Qing Lei, Dan-yun Lai, Hongyan Hou, He-wei Jiang, et al. (+19)
14 [GO] 2021―Jun―25 Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19 Yu Kaku, Takeo Kuwata, Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, et al. (+23)
15 [GO] 2021―Jun―23 Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell Maritza Puray-Chavez, Kyle M. LaPak, Travis P. Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, et al. (+25)
16 [GO] 2021―Jun―22 Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, et al. (+23)
17 [GO] 2021―Jun―11 Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help Jernej Pušnik, Enrico Richter, Bianca Schulte, Ramona Dolscheid-Pommerich, Christian Bode, Christian Putensen, et al. (+3)
18 [GO] 2021―Jun―08 Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L.C. Ketelaars, Michal Alon, et al. (+13)
19 [GO] 2021―Jun―08 Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7 Bo Meng, Steven A. Kemp, Guido Papa, Rawlings Datir, Isabella ATM. Ferreira, Sara Marelli, et al. (+22)
20 [GO] 2021―May―19 Direct Derivation of Human Alveolospheres for SARS-CoV-2 Infection Modeling and Drug Screening Toshiki Ebisudani, Shinya Sugimoto, Kei Haga, Akifumi Mitsuishi, Reiko Takai-Todaka, Masayuki Fujii, et al. (+9)
21 [GO] 2021―May―14 SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph Nichols, Deann T. Snyder, Jodi F. Hedges, et al. (+6)
22 [GO] 2021―May―13 Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells Robert Parker, Thomas Partridge, Catherine Wormald, Rebeca Kawahara, Victoria Stalls, Maria Aggelakopoulou, et al. (+10)
23 [GO] 2021―May―09 Dynamics of B-cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 Zachary Montague, Huibin Lv, Jakub Otwinowski, William S. DeWitt, Giulio Isacchini, Garrick K. Yip, et al. (+9)
24 [GO] 2021―May―03 METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection Na Li, Hui Hui, Bill Bray, Gwendolyn Michelle Gonzalez, Mark Zeller, Kristian G. Anderson, et al. (+5)
25 [GO] 2021―Apr―27 Hepatitis C Virus Drugs That Inhibit the SARS-CoV-2 Papain-Like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas B. Acton, et al. (+7)
26 [GO] 2021―Apr―27 Systematic Functional Analysis of SARS-CoV-2 Proteins Uncovers Viral Innate Immune Antagonists and Remaining Vulnerabilities Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, Rayhane Nchioua, Jan Hendrik Straub, Susanne Klute, et al. (+18)
27 [GO] 2021―Apr―24 Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 Xiaojuan Zhou, Fengge Ma, Jun Xie, Meng Yuan, Yunqiao Li, Namir Shaabani, et al. (+18)
28 [GO] 2021―Apr―23 Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection Jessie J.-Y. Chang, Daniel Rawlinson, Miranda E. Pitt, George Taiaroa, Josie Gleeson, Chenxi Zhou, et al. (+10)
29 [GO] 2021―Apr―15 SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery Apoorva Mulay, Bindu Konda, Gustavo Garcia, Changfu Yao, Stephen Beil, Jaquelyn Mary Villalba, et al. (+12)
30 [GO] 2021―Apr―05 Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells Peter AC. Wing, Thomas P. Keeley, Xiaodong Zhuang, Jeffrey Y. Lee, Maria Prange-Barczynska, Senko Tsukuda, et al. (+17)
31 [GO] 2021―Apr―03 SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine-Weber, Heike Hofmann-Winkler, et al. (+7)
32 [GO] 2021―Apr―02 Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction Shiho Torii, Chikako Ono, Rigel Suzuki, Yuhei Morioka, Itsuki Anzai, Yuzy Fauzyah, et al. (+4)
33 [GO] 2021―Mar―31 Cell-type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
34 [GO] 2021―Mar―23 Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, et al. (+9)
35 [GO] 2021―Mar―20 Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class Micah Rapp, Yicheng Guo, Eswar R. Reddem, Jian Yu, Lihong Liu, Pengfei Wang, et al. (+11)
36 [GO] 2021―Mar―19 Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, et al. (+22)
37 [GO] 2021―Mar―18 Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies Nicola Cotugno, Alessandra Ruggiero, Francesco Bonfante, Maria Raffaella Petrara, Sonia Zicari, Giuseppe Rubens Pascucci, et al. (+39)
38 [GO] 2021―Mar―14 Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients Yang Li, Ming-liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-yun Lai, et al. (+22)
39 [GO] 2021―Mar―07 The impact of Spike mutations on SARS-CoV-2 neutralization Chloe Rees-Spear, Luke Muir, Sarah A. Griffith, Judith Heaney, Yoann Aldon, Jonne L. Snitselaar, et al. (+15)
40 [GO] 2021―Feb―26 Metabolic programs define dysfunctional immune responses in severe COVID-19 patients Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordonez, Weiqiang Zhou, Ajay Vaghasia, Anne Hamacher-Brady, et al. (+20)
41 [GO] 2021―Feb―23 Use of convalescent serum reduces severity of COVID-19 in nonhuman primates Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney Woolsey, Krystle N. Agans, Daniel J. Deer, et al. (+4)
42 [GO] 2021―Feb―10 Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 Romain Gasser, Marc Cloutier, Jérémie Prévost, Corby Fink, Éric Ducas, Shilei Ding, et al. (+14)
43 [GO] 2021―Feb―05 SARS-CoV-2 ORF9b Inhibits RIG-I-MAVS Antiviral Signaling by Interrupting K63-Linked Ubiquitination of NEMO Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, et al. (+11)
44 [GO] 2021―Jan―26 Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 Timothy A. Bates, Jules B. Weinstein, Scotland Farley, Hans C. Leier, William B. Messer, Fikadu G. Tafesse
45 [GO] 2021―Jan―26 The immunodominant and neutralization linear epitopes for SARS-CoV-2 Shuai Lu, Xi-xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-rui Yang, et al. (+17)
46 [GO] 2021―Jan―22 Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients Anthony T. Tan, Martin Linster, Chee Wah Tan, Nina Le Bert, Wan Ni Chia, Kamini Kunasegaran, et al. (+10)
47 [GO] 2021―Jan―14 MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells Xin Yin, Laura Riva, Yuan Pu, Laura Martin-Sancho, Jun Kanamune, Yuki Yamamoto, et al. (+10)
48 [GO] 2021―Jan―14 Enhancement versus Neutralization by SARS-CoV-2 Antibodies from A Convalescent Donor Associates with Distinct Epitopes on the Receptor-Binding Domain Yunjiao Zhou, Zezhong Liu, Shibo Li, Wei Xu, Qianqian Zhang, Israel T. Silva, et al. (+19)
49 [GO] 2020―Dec―26 D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1/S2 junction Sophie M-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, et al. (+6)
50 [GO] 2020―Dec―17 Cell type-specific immune dysregulation in severely ill COVID-19 patients Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, et al. (+15)
51 [GO] 2020―Dec―01 A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 Takuya Tada, Chen Fan, Jennifer S. Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, et al. (+4)
52 [GO] 2020―Nov―19 The Roborovski dwarf hamster - a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection Jakob Trimpert, Daria Vladimirova, Kristina Dietert, Azza Abdelgawad, Dusan Kunec, Simon Dökel, et al. (+4)
53 [GO] 2020―Nov―13 The Human Leukocyte Antigen Class II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, Carl L. McMillian, Robert J. Konrad, Robert W. Siegel
54 [GO] 2020―Nov―03 HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon Jonathan J. Miner, Derek J. Platt, Cyrus M. Ghaznavi, Pallavi Chandra, Andrea Santeford, Amber M. Menos, et al. (+6)
55 [GO] 2020―Oct―20 High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States Ryan P. McNamara, Carolina Caro-Vegas, Justin T. Landis, Razia Moorad, Linda J. Pluta, Anthony B. Eason, et al. (+19)
56 [GO] 2020―Oct―12 Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes Tongqing Zhou, I-Ting Teng, Adam S. Olia, Gabriele Cerutti, Jason Gorman, Alexandra Nazzari, et al. (+32)
57 [GO] 2020―Sep―29 An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu, Sandhya Bangaru, et al. (+7)
58 [GO] 2020―Sep―23 Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Mu-Fan Chiu, Han-Chieh Kao, Sheng-Han Wang, et al. (+11)
59 [GO] 2020―Sep―19 Evasion of type-I interferon by SARS-CoV-2 Hongjie Xia, Zengguo Cao, Xuping Xie, Xianwen Zhang, John Yun-Chung Chen, Hualei Wang, et al. (+3)
60 [GO] 2020―Sep―06 Activation of the SARS-CoV-2 receptor Ace2 through JAK/STAT-dependent enhancers during pregnancy Lothar Hennighausen, Hye Kyung Lee
61 [GO] 2020―Sep―04 SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, et al. (+4)
62 [GO] 2020―Sep―03 A single-cell RNA expression map of human coronavirus entry factors Manvendra Singh, Vikas Bansal, Cédric Feschotte
63 [GO] 2020―Jul―24 A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 Yo-Min Liu, Md. Shahed-Al-Mahmud, Xiaorui Chen, Ting-Hua Chen, Kuo-Shiang Liao, Jennifer M. Lo, et al. (+6)
64 [GO] 2020―Jul―07 Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, et al. (+23)
65 [GO] 2020―Jul―03 Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection François Trottein, Harry Sokol
66 [GO] 2020―Jul―03 Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Chenjian Gu, Yanling Wu, et al. (+20)
67 [GO] 2020―May―30 Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2 Qi Peng, Ruchao Peng, Bin Yuan, Jingru Zhao, Min Wang, Xixi Wang, et al. (+6)
68 [GO] 2020―May―18 Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A.P. M. Perera, Wai Shing Leung, et al. (+13)
69 [GO] 2020―May―08 Publishing in a Pandemic: The View from Cell Reports The Cell Reports Editorial Team


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.017 sec